Intensity-Modulated Radiotherapy with a Simultaneous Integrated Boost Combined with Chemotherapy in Stages III-IV Hypopharynx-Larynx Cancer: Treatment Compliance and Clinical Outcomes
Table 1
Clinical characteristics of 60 patients with hypopharyngeal-laryngeal cancer.
Characteristics
(%)
Site
Hypopharynx
34 (56.7)
Larynx
26 (43.3)
Age (years)
Median (range)
63 (40–85)
Gender
Male
52 (86.7)
Female
8 (13.3)
Histological grading
G2
31 (51.7)
G3
29 (48.3)
T stage
T2
8 (13.3)
7T3
41 (68.3)
T4
11 (18.3)
N stage
N0
20 (33.3)
N1
13 (21.7)
N2
25 (41.7)
N3
2 (3.3)
Tumor stage
III
29 (48.3)
IV
31 (51.7)
Type of treatment
NCT-IMRT1
45 (75.0)
IMRT-CCT2
15 (25.0)
NCT-IMRT: induction chemotherapy followed by IMRT. 2IMRT-CCT: IMRT with concurrent administration of cisplatin.